These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28118022)

  • 1. Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.
    Meng Q; Lai YC; Kelly NJ; Bueno M; Baust JJ; Bachman TN; Goncharov D; Vanderpool RR; Radder JE; Hu J; Goncharova E; Morris AM; Mora AL; Shapiro SD; Gladwin MT
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):497-505. PubMed ID: 28118022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Alteration of Right Ventricle-Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction.
    Hubesch G; Dewachter C; Chomette L; Hupkens E; Jespers P; Vegh G; Doppler M; Sheikh Mohammad U; Thiriard A; Remmelink M; Vachiéry JL; McEntee K; Dewachter L
    J Am Heart Assoc; 2024 Jun; 13(11):e032201. PubMed ID: 38780193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.
    Raeisi-Giglou P; Lam L; Tamarappoo BK; Newman J; Dweik RA; Tonelli AR
    Clin Cardiol; 2017 Jun; 40(6):356-363. PubMed ID: 28026030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor Receptor.
    Kelly NJ; Radder JE; Baust JJ; Burton CL; Lai YC; Potoka KC; Agostini BA; Wood JP; Bachman TN; Vanderpool RR; Dandachi N; Leme AS; Gregory AD; Morris A; Mora AL; Gladwin MT; Shapiro SD
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):488-496. PubMed ID: 28085498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.
    Lai YC; Wang L; Gladwin MT
    J Physiol; 2019 Feb; 597(4):1143-1156. PubMed ID: 30549058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
    Wang L; Halliday G; Huot JR; Satoh T; Baust JJ; Fisher A; Cook T; Hu J; Avolio T; Goncharov DA; Bai Y; Vanderpool RR; Considine RV; Bonetto A; Tan J; Bachman TN; Sebastiani A; McTiernan CF; Mora AL; Machado RF; Goncharova EA; Gladwin MT; Lai YC
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1543-1558. PubMed ID: 32268788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
    van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
    Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
    JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension secondary to heart failure with preserved ejection fraction.
    Thenappan T; Prins KW; Cogswell R; Shah SJ
    Can J Cardiol; 2015 Apr; 31(4):430-9. PubMed ID: 25840094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
    Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
    Jheng JR; DesJardin JT; Chen YY; Huot JR; Bai Y; Cook T; Hibbard LM; Rupp JM; Fisher A; Zhang Y; Duarte JD; Desai AA; Machado RF; Simon MA; Lai YC
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1570-1583. PubMed ID: 38813697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Wood KC; Gladwin MT; Straub AC
    Heart; 2020 Apr; 106(8):562-568. PubMed ID: 31822569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.
    Levine AR; Simon MA; Gladwin MT
    Trends Cardiovasc Med; 2019 May; 29(4):207-217. PubMed ID: 30177249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.
    Berger JH; Shi Y; Matsuura TR; Batmanov K; Chen X; Tam K; Marshall M; Kue R; Patel J; Taing R; Callaway R; Griffin J; Kovacs A; Shanthappa DH; Miller R; Zhang BB; Roth Flach RJ; Kelly DP
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac reverse remodeling in a mouse model with many phenotypical features of heart failure with preserved ejection fraction: effects of modifying lifestyle.
    Aidara ML; Walsh-Wilkinson É; Thibodeau SÈ; Labbé EA; Morin-Grandmont A; Gagnon G; Boudreau DK; Arsenault M; Bossé Y; Couët J
    Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H1017-H1036. PubMed ID: 38363584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.
    Thenappan T; Shah SJ; Gomberg-Maitland M; Collander B; Vallakati A; Shroff P; Rich S
    Circ Heart Fail; 2011 May; 4(3):257-65. PubMed ID: 21411741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities.
    Hubesch G; Hanthazi A; Acheampong A; Chomette L; Lasolle H; Hupkens E; Jespers P; Vegh G; Wembonyama CWM; Verhoeven C; Dewachter C; Vachiery JL; Entee KM; Dewachter L
    Front Cardiovasc Med; 2021; 8():809885. PubMed ID: 35097026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
    Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.